Huashan Hospital: clinical-trial pipeline
Huashan Hospital is the sponsor of 246 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 85 are not yet finished and 3 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 180 |
| Phase 2 | 24 |
| Phase 3 | 14 |
| Phase 4 | 14 |
| Early phase 1 | 9 |
| Phase 1 | 2 |
| Phase 2/3 | 2 |
| Phase 1/2 | 1 |
Trials by status
| Status | Trials |
|---|---|
| Unknown | 102 |
| Recruiting | 58 |
| Completed | 56 |
| Not yet recruiting | 23 |
| Active, not recruiting | 4 |
| Withdrawn or not authorised | 2 |
| Terminated | 1 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 70 |
| Infectious disease and vaccines | 54 |
| Neurology | 30 |
| Nephrology and urology | 27 |
| Gastroenterology and liver | 26 |
| Cardiovascular | 21 |
| Respiratory | 16 |
| Metabolic and endocrine (diabetes, obesity) | 12 |
| Rare and genetic diseases | 8 |
| Immunology and rheumatology | 3 |
| Musculoskeletal | 3 |
| Dermatology | 2 |
Countries
| Country | Trials |
|---|---|
| China | 221 |
| United States | 1 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-20 | New trial posted | Tenapanor in Maintenance Hemodialysis Patients |
| 2026-09-28 | New trial posted | ImmunoADC Therapy for Induction Conversion in Patients With Stage IVB OSCC/OPSCC |
| 2026-09-22 | New trial posted | Efficacy and Safety of Cyclophosphamide in Amyotrophic Lateral Sclerosis |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT07571226 | Identification and Molecular Characterisation of Urban-environmental Stress Patterns Affecting Mental Illness | Not applicable | Recruiting | China |
| NCT06912282 | Bilateral Single-Electrode VO Combined With STN-DBS for Treating Meige Syndrome | Not applicable | Recruiting | China |
| NCT07245186 | Strategies for Proactive Health in People With Kidney Function Decline | Not applicable | Recruiting | China |
| NCT07644962 | Research Project on the Interaction Between Immune Function and Infectious Diseases in Older Adults and the D… | Not applicable | Not yet recruiting | |
| NCT06943729 | Clinical Safety and Efficacy of Flow-diverter in the Treatment of Intracranial Aneurysms | Not applicable | Recruiting | China |
| NCT06686979 | PDO Based Drug Sensitive Test in R/M SGC | Not applicable | Recruiting | China |
| NCT07634120 | Vertebrobasilar Dolichoectasia Treatment With Sirolimus | Phase 2 | Not yet recruiting | China |
| NCT07685301 | Development and Validation of an AI Foundation Model for CNS Tumor Classification | Not applicable | Not yet recruiting | |
| NCT05387369 | A Real World Study of Paxlovid for the Treatment of Hospitalized Patients Confirmed With COVID-19 | Not applicable | Recruiting | China |
| NCT06900166 | Pegylated Interferon Alfa-2b in Reducing Relapse Rates After Nucleos(t)ide Analogue Withdrawal in HBeAg-negat… | Phase 4 | Not yet recruiting | China |
| NCT06553911 | Exploring the Application Efficacy of Artificial Intelligence (AI) Diagnostic Tools in Medical Imaging (MI) o… | Not applicable | Recruiting | China |
| NCT04020536 | Real World Study of Classic Infectious Disease | Not applicable | Recruiting | China |
| NCT06994975 | CHinese ischEmic Stroke Beyond 4.5 Hours With TeNecteplase Under Optimized Non-Contrast CT Selection | Phase 3 | Recruiting | China |
| NCT07844551 | ImmunoADC Therapy for Induction Conversion in Patients With Stage IVB OSCC/OPSCC | Phase 2 | Not yet recruiting | |
| NCT07703605 | AI-Assisted MRI Molecular Subtyping in Pediatric Brain Tumors | Not applicable | Not yet recruiting | |
| NCT07552792 | Impact of Hand Rub Placement on Patient Trust and Disease Stigma | Not applicable | Not yet recruiting | |
| NCT06102837 | Tumor Vaccines for Solid Tumors | Not applicable | Recruiting | China |
| NCT06515132 | Efficacy and Safety of Spinal Cord Stimulation in Patients With Spinal Cord Stimulation | Not applicable | Recruiting | China |
| NCT07741279 | Real-World Study of Enarodustat for Anemia in Non-Dialysis CKD Patients | Not applicable | Recruiting | China |
| NCT04535843 | Precision Diagnosis and Prospective Cohort Study for Myasthenia Gravis: Multicenter Analysis in China | Not applicable | Recruiting | China |
| NCT06775080 | The Use of Propranolol in the Perioperative Period of Resectable Gastrointestinal Tumors | Phase 2 | Recruiting | China |
| NCT05965128 | Promotion and Application of a New Three-level Etiological Diagnosis Strategy for Fever Clinics in Respirator… | Not applicable | Recruiting | China |
| NCT07882017 | Tenapanor in Maintenance Hemodialysis Patients | Not applicable | Not yet recruiting | China |
| NCT06241521 | Myasthenia Gravis Registry in China | Not applicable | Recruiting | China |
| NCT06781944 | OBINOTUZUMAB Versus Cyclophosphamide + Glucocorticoids in Primary Membranous Nephropathy(Blossom Study) | Phase 3 | Recruiting | China |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Huashan Hospital clinical trials: 85 open, 16 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/huashan-hospital/, data as of 2026-10-25.